IMPACT OF L. REUTERII SUPPLEMENTATION ON ANTI-H. PYLORI SECOND LINE THERAPY-RELATED

被引：0
|
作者：
Ainora, M. E. [1 ]
Nista, E. C. [1 ]
Vitale, G. [1 ]
Ojetti, V. [1 ]
Cesario, V. [1 ]
Gigante, G. [1 ]
Sparano, L. [1 ]
Novi, M. L. [1 ]
Roccarina, D. [1 ]
Cammarota, G. [1 ]
Gasbarrini, G. [1 ]
Gasbarrini, A. [1 ]
机构：
[1] Policlin A Gemelli, Rome, Italy
来源：
DIGESTIVE AND LIVER DISEASE | 2008年 / 40卷
关键词：
D O I：
10.1016/S1590-8658(08)60224-8
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
PA.29
引用
收藏
页码：S86 / S86
页数：1
相关论文
共 50 条
  • [41] Impact of First-Line Arsenic Trioxide and Retinoic Acid Treatment on Outcome in Therapy-Related Acute Promyelocytic Leukemia Patients
    Kayser, S.
    Krzykalla, J.
    Norsworthy, K.
    Elliott, M.
    Grimwade, D.
    Hills, R. K.
    Gonzales, P.
    Racil, Z.
    Mayer, J.
    Baer, M. R.
    Novak, J.
    Zak, P.
    Szotkowski, T.
    Russell, N. H.
    Westermann, J.
    Walter, R. B.
    Estey, E. H.
    Goerner, M.
    Benner, A.
    Kraemer, A.
    Smith, B. D.
    Burnett, A. K.
    Thiede, C.
    Roellig, C.
    Ho, A. D.
    Ehninger, G.
    Tallman, M.
    Levis, M. J.
    Platzbecker, U.
    ANNALS OF HEMATOLOGY, 2017, 96 : S75 - S76
  • [42] The Trend of Eradication Rates of First-Line Therapy and Second-Line Quadruple Therapy Containing Metronidazole for H. pylori Infection for Recent Five Years
    Park, J.
    Park, S.
    Kim, G.
    Seoul, S.
    Moon, J.
    Jee, S.
    Jung, H.
    Lee, D.
    Kim, J.
    Lee, S.
    HELICOBACTER, 2009, 14 (04) : 400 - 400
  • [43] GELATINE TANNATE SUPPLEMENTATION REDUCES ANTIBIOTICS ASSOCIATED SIDE-EFFECTS OF ANTI-HELICOBACTER PYLORI FIRST-LINE THERAPY
    Gigante, G.
    Caracciolo, G.
    Campanale, M.
    Cesario, V.
    Bove, V.
    Cammarota, G.
    Gasbarrini, G.
    Gasbarrini, A.
    HELICOBACTER, 2013, 18 : 134 - 134
  • [44] 14-Day bismuth high dose dual therapy is a robust second-line rescue therapy of H. pylori infection
    Leow, Alex Hwong-Ruey
    Goh, Khean-Lee
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 : 83 - 83
  • [45] Levofloxacin based triple therapy as second-line treatment for H. pylori infection after failure of standard triple therapy.
    Festa, V
    Perri, F
    Boschetto, S
    Giovannone, M
    Tosoni, M
    Andriulli, A
    Barberani, F
    GASTROENTEROLOGY, 2002, 122 (04) : A587 - A587
  • [46] First-line versus Second-Line Anti-PD-(L)1 Therapy for Patients with Positive PD-L1 Expression
    Barlesi, F.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1677 - S1677
  • [47] Impact of Second-Line Anti-GD2 Therapy in a Patient with Relapsed, Metastatic Ewing Sarcoma
    Dombrowski, F.
    Lode, H.
    PEDIATRIC BLOOD & CANCER, 2021, 68 : S492 - S492
  • [48] EFFICACIES OF POTASSIUM-COMPETITIVE ACID BLOCKER-BASED HIGHDOSE DUAL THERAPY, POTASSIUM-COMPETITIVE ACID BLOCKER-BASED TRIPLE THERAPY AND PROTON PUMP INHIBITOR-BASED REVERSE HYBRID THERAPY IN THE FIRST-LINE ANTI-H. PYLORI TREATMENT
    Hsu, Ping-I
    Chen, Chien-Lin
    Shih, Chih-An
    Chen, Kuan-Yang
    Lee, Chia-Long
    Chuah, Seng-Kee
    Tsay, Feng-Woei Tsay
    Wang, Jiunn-Wei
    Wu, Deng-Chyang
    GASTROENTEROLOGY, 2023, 164 (06) : S375 - S375
  • [49] Levofloxacin-based triple therapy versus bismuth-based quadruple therapy as a second line treatment for the eradication of H. pylori infection
    Karatapanis, S.
    Skorda, L.
    Georgopoulos, S.
    Papantoniou, N.
    Papastergiou, V.
    Ntoutsikos, K.
    Komnianides, K.
    Lisgos, Ph
    ANNALS OF GASTROENTEROLOGY, 2009, 22 (04): : 263 - 267
  • [50] Low dose quadruple therapy for two weeks as "second line" treatment for cure of H-pylori infection after failure of standard triple therapy
    Pieramico, O
    Zanetti, MV
    GUT, 2002, 51 : A98 - A98
12345